A Study to Evaluate Camoteskimab in Participants With Still's Disease
Clinical trial NCT04752371 · TERMINATED
Trial details
- NCT number
- NCT04752371
- Sponsor
- Apollo Therapeutics Ltd
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-25
- Primary completion
- 2022-05-24
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.